Related Experiment Video

Updated: Apr 26, 2026

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings
04:16

Individualized Reconstitution of Human Milk Microbiota: A Feasible Approach in Real-World Settings

Published on: February 7, 2025

1.0K

[Human milk in hospitalized premature neonates and nutritional evolution]

Carolina E Argüello, María D Defagó

    Revista De La Facultad De Ciencias Medicas (Cordoba, Argentina)
    |July 19, 2014
    PubMed

    Insights

    Human milk (HM) intake positively impacts hemoglobin levels in very low birth weight premature newborns (VLBW-PN). Cesarean delivery is linked to reduced HM provision for these vulnerable infants.

    Area of Science:

    • Neonatology
    • Human Milk Research
    • Nutritional Science

    Context:

    • Preterm infants, particularly low birth weight premature newborns (LBW-PN) and very low birth weight premature newborns (VLBW-PN), have unique nutritional requirements for adequate growth.
    • Human milk (HM) is recognized as the optimal nutrition for neonates, but its contribution to vulnerable premature infants during hospitalization requires evaluation.

    Purpose:

    • To assess the role of human milk (HM) in the nutritional status of low birth weight premature newborns (LBW-PN) and very low birth weight premature newborns (VLBW-PN) during hospitalization.
    • To investigate maternal factors influencing HM intake and its relationship with key nutritional parameters in these infants.

    Summary:

    • A study involving 87 LBW-PN and 82 VLBW-PN found limited HM intake, with only 36.36% of VLBW-PN and 31.02% of LBW-PN receiving over 20% of their diet as HM.
    • Higher HM intake correlated with improved hemoglobin concentration at discharge in VLBW-PN. A significant association was found between HM amount and height at discharge for premature infants receiving less than 20% HM.
    • A high prevalence of cesarean deliveries was noted, which was associated with lower HM contributions to the newborns.

    Impact:

    • Human milk (HM) plays a crucial role in stabilizing hemoglobin levels in premature infants.
    • Findings suggest that cesarean delivery might be a factor associated with reduced human milk provision, impacting the nutritional support for newborns.
    Abstract

    More Related Videos

    Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers09:36

    Effect of Hyaluronic Acid 35 kDa on an In Vitro Model of Preterm Small Intestinal Injury and Healing Using Enteroid-Derived Monolayers

    Published on: July 28, 2022

    1.8K
    Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation09:02

    Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation

    Published on: February 15, 2018

    18.7K

    Related Concept Videos

    Development of Human Microbiota01:30

    Development of Human Microbiota

    The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
    60
    Development of the Oral Microbiota01:28

    Development of the Oral Microbiota

    The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
    62
    Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

    Pharmacokinetics in Pediatric Patients: Drug Distribution

    Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
    547
    Parentral Nutrition: Centeral and Peripheral Parental Nutrition01:27

    Parentral Nutrition: Centeral and Peripheral Parental Nutrition

    Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
    PN can be administered through two primary routes:
    1. Central Parenteral Nutrition (CPN):
    CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
    2.0K
    Development of Immunocompetence01:22

    Development of Immunocompetence

    The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
    The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
    Subsequent T...
    1.2K
    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

    Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

    Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
    954